[1]陈文铎,黄越,董淼,等.10-羟基喜树碱衍生物的合成及其抗肿瘤活性的初步研究[J].浙江理工大学学报,2013,30(05):742-746.
　CHEN Wen duo,HUANG Yue,DONG Miao,et al.Preliminary Research on Synthesis of 10hydroxycamptothecine Derivative and Its Antineoplastic Activity[J].Journal of Zhejiang Sci-Tech University,2013,30(05):742-746.

点击复制

10-羟基喜树碱衍生物的合成及其抗肿瘤活性的初步研究()

分享到：

参考文献/References:

［1］ 袁丹, 容如滨, 喻宗沅, 等. 抗肿瘤药物10-羟基喜树碱的研究与应用进展［J］. 化学与生物工程, 2008, 24(12): 9-11.
［2］ 王磊, 李玉艳, 尤启冬. DNA 拓扑异构酶Ⅰ抑制药: 抗肿瘤药喜树碱类衍生物的研究进展［J］. 中国药师, 2003, 6(7): 402-405.
［3］ 潘显道, 王存英. 天然抗肿瘤药喜树碱衍生物的研究进展［J］. 药学学报, 2008(9): 715-720.
［4］ Zolotarskaya O Y, Wagner A F, Beckta J M, et al. Synthesis of water soluble camptothecinpolyoxetane conjugates via click chemistry［J］. Molecular Pharmaceutics, 2012, 9(11): 3403-3408.
［5］ Ulukan H, Swaan P W. Camptothecins: a review of their chemotherapeutic potential［J］. Drugs, 2002, 62(14): 2039-2057.
［6］ Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology and interfacial inhibition［J］. Chemical Reviews, 2009, 109(7): 2894-2905.
［7］ Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity［J］. J Med Chem, 1998, 41(1): 31-37.
［8］ Safavy A. Recent developments in taxane drug delivery［J］. Current Drug Delivery, 2008, 5(1): 42-54.
［9］ Lu H, Lin H, Jiang Y, et al. Synthesis and antitumor activity of 20Olinked succinate-based camptothecin ester derivatives［J］. Letters in Drug Design; Discovery, 2006, 3(2): 83-86.
［10］ 袁飞, 何琳, 丁沐淦, 等. 静态法与动态法测定药物水中溶解度的探讨［J］. 广东药学院学报, 2010, 26(5): 462-464.
［11］ Herrmann M, Lorenz H, Voll R, et al. A rapid and simple method for the isolation of apoptotic DNA fragments［J］. Nucleic Acids Research, 1994, 22(24): 5506-5511.
［12］ Janss A J, Cnaan A, Zhao H, et al. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines［J］. Anticancer Drugs, 1998, 9(7): 641-652.
［13］ Lavergne O, Lesueur Ginot L, Rodas F P, et al. Homocamptothecins: synthesis and antitumor activity of novel E-ring modified camptothecin analogues［J］. Journal of Medicinal Chemistry, 1998, 41(27): 5410-5419.
［14］ Song L, Bevins R, Anderson B D. Kinetics and mechanisms of activation of alphaamino acid ester prodrugs of camptothecins［J］. J Med Chem, 2006, 49(14): 4344-4355.
［15］ Greenwald R B, Pendri A, Conover C D, et al. Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity［J］. Bioorganic & Medicinal Chemistry, 1998, 6(5): 551-562.